It has been a mixed year for REGENXBIO Inc. insiders: $950,000 bought by one person and $940,000 sold by one, so more buying than selling overall.
The largest purchase came from Ciongoli Gregory Austin (Director), about $500,000.
Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters. Big money check: 165 institutions held RGNX as of Q2 2026, and funds were split between buying and selling.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | Buy | 49,196 | $9.14 | $450K | SEC |
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | Buy | 53,407 | $9.36 | $500K | SEC |
| Jul 6, 2026 | PAKOLA STEVE | Executive Officer | Sell | 2,161 | $13.64 | $29K | SEC |
| Jul 1, 2026 | PAKOLA STEVE | Executive Officer | Sell | 19,608 | $11.04 | $216K | SEC |
| Jul 1, 2026 | PAKOLA STEVE | Executive Officer | Sell | 36,725 | $12.86 | $472K | SEC |
| May 13, 2026 | PAKOLA STEVE | Executive Officer | Sell | 15,309 | $11.02 | $169K | SEC |
| Mar 12, 2026 | PAKOLA STEVE | Executive Officer | Sell | 5,124 | $10.35 | $53K | SEC |
| Oct 10, 2025 | Simpson Curran | CEO | Sell | 20,811 | $12.62 | $263K | SEC |
| Oct 1, 2025 | Simpson Curran | CEO | Sell | 7,624 | $10.03 | $76K | SEC |
| Sep 12, 2025 | Simpson Curran | CEO | Sell | 7,734 | $10.02 | $77K | SEC |
| May 14, 2025 | Mills Kenneth T. | Director | Sell | 20,602 | $7.91 | $163K | SEC |
| Oct 2, 2024 | KARABELAS ARGERIS N | Director | Sell | 10,000 | $10.11 | $101K | SEC |
| Sep 4, 2024 | KARABELAS ARGERIS N | Director | Sell | 700 | $12.34 | $9K | SEC |
| Sep 4, 2024 | KARABELAS ARGERIS N | Director | Sell | 9,300 | $11.50 | $107K | SEC |
| Aug 5, 2024 | Simpson Curran | CEO | Sell | 100 | $15.00 | $2K | SEC |
In the last 12 months REGENXBIO Inc. insiders made open-market purchases worth about $950,000 and sales worth about $940,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in RGNX was filed on 2026-08-27.
165 investment managers reported holding RGNX in SEC Form 13F filings for Q2 2026.
No congressional trades in RGNX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).